InvestorsHub Logo
Followers 3
Posts 231
Boards Moderated 0
Alias Born 07/28/2011

Re: DewDiligence post# 16393

Wednesday, 01/18/2017 5:31:01 PM

Wednesday, January 18, 2017 5:31:01 PM

Post# of 20689
Despite the multitude of Humira biosimilars in the pipeline and the general lack of clarity on those applications, but after re-reading the draft guidance the early articles and comments -- I am going out on a limb and predicting that MNTA will be granted the first AB rated interchangeable Humira.